// App-Quantinova.ai

: Time from referral to definitive treatment in Cushing’s syndrome

Researchers

Presenter

  • Amy Coulden

Principal Investigators

  • Simon Aylwin

  • Daniel Flanagan

  • Yaasir Mamoojee

  • Aparna Pal

  • Neil Gittoes

  • Helena Gleeson

Medical Centers

  • University of Birmingham, Institute of Metabolism and Systems Research, Birmingham, United Kingdom

  • Queen Elizabeth Hospital Birmingham, Endocrinology, Birmingham, United Kingdom

  • University of Birmingham, Centre for Endocrinology, Diabetes and Metabolism (CEDAM), Birmingham, United Kingdom

  • Kings College Hospital NHSFT, Endocrinology, London, United Kingdom

  • University Hospitals Plymouth NHSFT, Endocrinology, Plymouth, United Kingdom

  • The Newcastle upon Tyne Hospitals, Endocrinology and Metabolic medicine, Newcastle upon Tyne, United Kingdom

  • Oxford University Hospitals NHSFT, Endocrinology, Oxford, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Endocrine/metabolic Diseases (ME)

Disease

  • Cushing's syndrome

Biomarkers

  • Adrenocorticotropic hormone

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • N/A

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved